Zusammenfassung
□ Hintergrund
In den vergangenen Jahren ist die Untersuchung des autonomen Nervensystems insbesondere im Bereich der Diabetologie, aber auch in anderen Bereichen der inneren Medizin mehr und mehr in den Blickpunkt des Interesses getreten. Eine vergleichende Untersuchung der autonomen Nervenfunktion bei Patienten mit verschiedenen chronischen Erkrankungen, die mit Autoimmunphänomenen einhergehen, mit standardisierten Untersuchungsverfahren wurde bisher noch nicht vorgestellt. Aufgabe dieser Studie war daher, die vergleichende Erfassung der Häufigkeit und des Ausprägungsgrades der autonomen und somatosensiblen Neuropathie bei Patienten mit Morbus Crohn, Colitis ulcerosa, systemischem Lupus erythematodes, progressiver Systemsklerose und Typ-I-Diabetes mellitus.
□ Patienten und Methoden
Es wurden 28 Patienten mit Morbus Crohn (Alter: 32,4±2,0 Jahre), 17 mit Colitis ulcerosa (39,7±3,6 Jahre), 39 mit systemischem Lupus erythematodes (34,9±2,0 Jahre), 38 mit progressiver Systemsklerose (51,5±2,4 Jahre) und 65 mit Typ-I-Diabetes mellitus (35,5±1,6 Jahre) untersucht. Die kardiovaskuläre autonome (cANP), die pupilläre autonome (pANP) und die somatosensible Neuropathie (ssNP) wurden mittels standardisierter Testverfahren beurteilt.
□ Ergebnisse
Folgende Häufigkeiten wurden für die cANP, pANP und ssNP gefunden: Morbus Crohn (0%, 19%, 7%), Colitis ulcerosa (6%, 25%, 18%), systemischer Lupus erythematodes (5%, 29%, 10%), progressive Systemsklerose (11%, 16%, 32%) und Typ-I-Diabetes mellitus (26%, 66%, 29%).
□ Schlußfolgerung
Diese Untersuchungen zeigen, daß Typ-I-Diabetiker von einer Neuropathie am häufigsten und am schwersten betroffen waren. Aber auch bei Patienten mit anderen chronischen Erkrankungen, insbesondere systemischerm Lupus erythematodes, progressiver Systemsklerose und Colitis ulcerosa, ist eine Neuropathie des autonomen Nervensystems sehr viel häufiger, als bisher vermutet wurde. Patienten mit chronisch-entzündlichen Darmerkrankungen haben selten eine cANP. Patienten mit progressiver Systemsklerose haben häufig eine somatosensible Neuropathie. Die verschiedenen Krankheitsgruppen unterscheiden sich im Muster und im Ausprägungsgrad der autonomen und somatosensiblen Neuropathie, was auf unterschiedliche neuropathogenetische Mechanismen hinweist.
Summary
□ Background
During the last years, examination of autonomic nervous function and of autonomic neuropathy has attracted attention not only in diabetes mellitus research but also in other areas of internal medicine. However, patients with various chronic diseases with autoimmune phenomenons have never been investigated in a comparative study with standardized examination techniques. Hence, the aim of the study was to examine the prevalence and the severity of autonomic neuropathy in patients with the following chronic diseases.
□ Patients and Methods
We investigated 28 patients with Crohn’s disease (CD; age: 32.4±2.0 y), 17 patients with ulcerative colitis (UC; 39.7±3.6 y), 39 patients with systemic lupus erythematosus (SLE; 34.9±2.0 y), 38 patients with progressive systemic sclerosis (pSS; 51.5±2.4 y) and 65 patients with insulin-dependent diabetes mellitus (IDDM; 35.5±1.6 y). Cardiovascular autonomic (cANP), pupillary autonomic (pANP), and sensorimotor (ssNP) neuropathy were assessed by standardized techniques.
□ Results
Prevalence rates for cANP, pANP and ssNP were found to be 0%, 19%, and 7% in CD, 6%, 25%, and 18% in UC, 5%, 29%, and 10% in SLE, 11%, 16%, and 32% in pSS, and 26%, 66%, and 29% in IDDM, respectively.
□ Conclusion
The study demonstrated patients with IDDM to have the highest prevalence rates of cANP and pANP. Patients with other chronic diseases, particularly SLE, pSS and UC, had high prevalence rates of pANP. This may be due to alterations of structures of the central nervous system in these patients. cANP was rare in patients with inflammatory bowel disease and ssNP was found very often in patients with pSS, probably due to local fibrotic lesions. The various disease groups differ in the pattern and severity of autonomic and sensorimotor neuropathy, which indicates that different structures and neuropathogenic mechanisms may be involved.
Literatur
Best, W. R., J. M. Becktel, J. W. Singleton, F. Kern Jr.: Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70 (1976), 439–444.
Brown, F. M., S. J. Brink, R. Freeman, S. L. Rabinowe: Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis. Diabetes 38 (1989), 938–941.
Brownlee, M., H. Vlassara, A. Cerami: Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus. Diabetes 35 (1986), 999–1003.
Dahlgaard, T., V. K. Nielsen, J. K. Kristensen: Vibratory perception in patients with generalised scleroderma. Quart. J. Med. 80 (1991), 119–122.
Dessein, P. H., B. I. Joffe, R. M. Metz, D. L. Millar, M. Lawson, A. E. Stanwix: Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Amer. J. Med. 93 (1992), 143–150.
Duncan, G., R. M. Johnson, D. G. Lambie, E. A. Whiteside: Evidence of vagal neuropathy in chronic alcoholics. Lancet 2 (1980), 1053–1057.
Ewing, D. J., B. F. Clarke: Diagnosis and management of diabetic autonomic neuropathy. Brit. med. J. 285 (1982), 916–918.
Fisher, L. A.: Central autonomic modulation of cardiac baroreflex by corticotropin-releasing factor. Amer. J. Physiol. 256 (1989), H949-H955.
Genovely, H., M. A. Pfeifer: RR-Variation: The autonomic test of choice in diabetes. Diab. Metab. Rev. 4 (1988), 255–271.
Geissler, A., T. Andus, M. Roth, F. Kullmann, I. Caesar, P. Held, V. Gross, S. Feuerbach, J. Schölmerich: Focal white matter lesions in brain of patients with inflammatory bowel disease. Lancet 345 (1995), 897–898.
Gledhill, R.F., P.H. Dessein: Autonomic neuropathy in systemic lupus erythematosus (letter). J. Neurol. Neurosurg. Psychiat. 51 (1988), 1238–1240.
Greene, D. A., S. A. Lattimer, A. A. F. Sima: Pathogenesis and prevention of diabetic neuropathy. Diab. Metab. Rev. 4 (1988), 201–221.
Hanly, J. G., J. D. Fisk, B. Eastwood: Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus. Lupus 3 (1994), 193–199.
Heuer, D. K., W. E. Gager, F. H. Reeser: Ischemic optic neuropathy associated with Crohn’s disease. J. clin. Neurol. Ophthal. 2 (1982), 175–181.
Hietarharju, A., S. Jaaskelainen, M. Hietarinta, H. Frey: Central nervous system involvement and psychiatric manifestations in systemic sclerosis: clinical and neurophysiological evaluation. Acta neurol. scand. 87 (1993), 382–387.
Lindgren, S., B. Lilja, I. Rosen, G. Sundkvist: Disturbed autonomic nerve function in patients with Crohn’s disease. Scand. J. Gastroent. 26 (1991), 361–366.
Low, P. A. (Hrsg): Clinical autonomic disorders. Little, Brown & Co., Boston-Toronto-London 1993.
Low, P. A., J. C. Walsh, C. Y. Huang, J. G. McLeod: The sympathetic nervous system in alcoholic neuropathy: A clinical and pathological study. Brain 98 (1975), 357–364.
Luft, D., O. B. Pagallies, K. Konz, K. Mann, W. Renn, M. Eggstein: Differential diagnosis of neuropathic lesions in diabetic and alcoholic patients. Clin. Invest. 72 (1994), 200–205.
Magaro, M., L. Mirone, L. Altomonte, A. Zoli, S. Angelosante: Lack of correlation between anticardiolipin antibodies and peripheral autonomic nerve involvement in systemic lupus erythematosus. Clin. Rheum. 11 (1992), 231–234.
Mevorach, D., E. Raz, I. Steiner: Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement. Lupus 3 (1994). 117–121.
Neil, H. A. W., A. V. Thompson, S. John et al.: Diabetic autonomic neuropathy: The prevalence of impaired heart rate variability in a geographically defined population. Diab. Med. 6 (1989), 20–24.
Pfeifer, M. A., C. R. Weinberg, D. L. Cook, A. Reenan, J. B. Halter, J. W. Ensinck, D. Porter jr: Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diab. Care 7 (1984), 447–453.
Rabinowe, S. L., F. M. Brown, M. Watts, A. M. Smith: Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Autonomic brake index and heart-rate variation. Diab. Care 14 (1990), 1084–1088.
Rachmilewitz, D.: Coated mesalazine (5-amino-salicylic acid) versus sulphasalazine in the treratment of active ulcerative colitis: a randomized trial. Brit. med. J. 198 (1989), 82–86.
Ratzmann, K. P., M. Raschke, I. Gander, E. Schimke: Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II diabetes. J. Diab. Complicat. 5 (1991), 1–5.
Ryder, R. E. J., R. L. Kennedy, P. G. Newrick, R. M. Wilson, J. D. Ward, C. A. Hardisty: Autonomic denervation may be a prerequisite of diabetic neuropathic foot ulceration. Diab. Med. 7 (1990), 726–730.
Schnell, O., C. M. Kirsch, J. Stemplinger, M. Haslbeck, E. Standl: Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 38 (1995), 1345–1352.
Sedwick, L. A., T. G. Klingele, R. M. Burde, M. M. Behrens: Optic neuritis in inflammatory bowel disease. J. clin. Neurol. Ophthal. 4 (1984), 3–6.
Sibley, J. T., W. P. Olszynski, W. E. Decoteau, M. B. Sundaram: The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J. Rheum. 19 (1992), 47–52.
Smith, S. A.: Reduced sinus arrhythmia in diabetic autonomic neuropathy: diagnostic value of an age-related normal range. Brit. med. J. 285 (1982), 1599–1601.
Straub, R. H., U. Thies, L. Kerp: The pupillary light reflex. I. Age-dependent and age-independent parameters in normal subjects. Ophthalmologica 204 (1992), 134–142.
Straub, R. H., B. J. Arnolds, L. Kerp: Biometry with a video-genlock interface and a computer-based image-analyzing system: use as a TV-video-pupillometer. Biomed. Instr. Technol. 27 (1993), 43–48.
Straub, R. H., L. Rokitzki, T. Schumacher, C. Hillmann, K.-D. Palitzsch, J. Schölmerich: Bei Patienten mit Typ-II-Diabetes mellitus und Neuropathie besteht kein Mangel an den Vitaminen A, E, β-Carotin, B1, B2, B6, B12 und Folsäure. Med. Klin. 88 (1993), 453–457.
Straub, R. H., U. Thies, A. Jeron, K.-D. Palitzsch, J. Schölmerich: Valid parameters for investigation of the pupillary light reflex in normal and diabetic subjects shown by factor analysis and partial correlation. Diabetologia 37 (1994), 414–419.
Straub, R. H., M. Thum, C. Hollerbach, K.-D. Palitzsch. J. Schölmerich: Impact of obesity on neuropathic late complications in NIDDM Diab. Care 17 (1994), 1290–1294.
Straub, R. H., B. Zietz, K.-D. Palitzsch, J. Schölmerich: Impact of disease duration on cardiovascular and pupillary autonomic nervous function in IDDM and NIDDM patients. Diab. Care 19 (1996), 960–967.
Straub, R. H., B. Lang, K.-D. Palitzsch, J. Schölmerich: Estimation of the cut-off value in cardiovascular autonomic nervous function tests: Not-age-related criteria or the age-related 5th percentile. J. Diab. Complicat. (in press).
Sundkvist, G., L. A. Velloso, O. Kämpe, S. L. Rabinowe, S. A. Ivarsson, B. Lilja, F. A. Karlsson: Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients. Diabetologia 37 (1994), 293–299.
Suarez-Almazor, M. E., E. Bruera, A. S. Russell: Normal cardiovascular autonomic function in patients with systemic sclerosis (CREST variant). Ann. rheum. Dis. 47 (1988), 672–674.
Tan, E. M., A. S. Cohen, J. F. Fries et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr. and Rheum. 25 (1982), 1271–1277.
Tesfaye, S., R. Malik, J. D. Ward: Vascular factors in diabetic neuropathy. Diabetologia 37 (1994), 847–854.
Watkins, P. J., J. D. Mackay: Cardiac denervation in diabetic neuropathy. Ann. Intern. Med. 92 (1980), 304–307.
Weinberg, C. R., M. A. Pfeifer: An improved method for measuring heart-rate variability: assessment of cardiac autonomic function. Biometrics 40 (1984), 855–861.
Yasuda, H., P. J. Dyck: Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology (Minneap.) 37 (1987), 20–28.
Ziegler, D., G. Laux, K. Dannehl, M. Spüler, H. Mühlen, P. Mayer, F. A. Gries: Assessment of cardiovascular autonomic function: Age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diab. Med. 9 (1991), 166–175.
Zvaifler, N. J., H. G. Bluestein: The pathogenesis of central nervous system manifestations of systemic lupus erythemtosus. Arthr. and Rheum. 25 (1982), 862–866.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Straub, R.H., Andus, T., Lock, G. et al. Kardiovaskuläre und pupilläre autonome und somatosensible Neuropathie bei chronischen Erkrankungen mit Autoimmunphänomenen. Med. Klin. 92, 647–653 (1997). https://doi.org/10.1007/BF03044820
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03044820
Schlüsselwörter
- Autonome Neuropathie
- Sornatosensible Neuropathie
- Diabetes mellitus
- Morbus Crohn
- Colitis ulcerosa
- Progressive Systemsklerose
- Systemischer Lupus erythematodes